Please login to the form below

Not currently logged in
Email:
Password:

Algeta

This page shows the latest Algeta news and features for those working in and with pharma, biotech and healthcare.

Relay Therapeutics strengthens team

Relay Therapeutics strengthens team

He has held roles for Keryx Biopharmaceutical, Algeta ASA and AVEO Oncology.

Latest news

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Pharma deals during June 2014 Pharma deals during June 2014

    Bayer paid 50m ($68m) upfront payment with further milestones in return for global rights which should complement Xofigo (from the acquisition of Algeta). The companies will jointly fund the phase III

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    Hyperlipidemia. 2, 600. Algeta / Bayer. Acquisition. Buys out deal for Xofigo radiotherapeutic for.

  • Pharma deals during November 2013 Pharma deals during November 2013

    Algeta, has been noted as being rather ungenerous, with room for upping the offer. This takeover was an obvious tactic bringing in the key the asset, Xofigo which has been under ... with Algeta under which there was US co-promotion for 50 per cent of

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Targovax appoints chief financial officer Targovax appoints chief financial officer

    He also brings experience from cancer biotech Algeta ASA, and management consulting expertise from McKinsey &Company's pharma and healthcare practice.

  • Targovax appoints Oystein Soug as CEO Targovax appoints Oystein Soug as CEO

    He has previously served as chief financial officer for Algeta, a Norwegian oncology biotech that was bought by Bayer in 2014, and spent six years at Orkla, a Norwegian consumer goods

  • Algeta execs join Targovax Algeta execs join Targovax

    Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta. ... Aksnes was most recently VP clinical research at Algeta, which was taken over by pharma giant Bayer

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics